Propanc Biopharma, Inc. Common Stock (PPCB) — Long-term Investment Intensity
Propanc Biopharma, Inc. Common Stock (PPCB) has a Long-term Investment Intensity of 0.8% as of March 2019. Long-term investments of $2.13K represent 0.8% of total assets of $259.92K. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Propanc Biopharma, Inc. Common Stock net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Annual Long-term Investment Intensity for Propanc Biopharma, Inc. Common Stock (None–None)
The table below presents the year-by-year Long-term Investment Intensity for Propanc Biopharma, Inc. Common Stock from None to None, covering 0 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see PPCB company net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|